Challenges of the Valley of Death in the Iranian Biomedical Innovation Ecosystem and Investigating Effective Capabilities and Context

A study of the development of different innovation ecosystems has shown that in the early stages of ecosystem development we are faced with a period in which, due to the different natures of the two soldiers, the ecosystem faces challenges with the highest failure and stopping rates. It comes with it. Ecosystems that can pass this stage are able to acquire the value produced in the ecosystem and create wealth. In this study, we seek to identify the challenges of this stage of the growth process called the Death Valley of the ecosystem and identify the capabilities needed to overcome it. Therefore, this article tries to investigate its challenges and the underlying factors and capabilities affecting the passage of the innovation ecosystem by examining the case of Iran's biopharmaceutical innovation ecosystem as a successful ecosystem that has been able to cross the Death Valley. To do this, the required data were collected through semi-structured interviews and analyzed in the form of a model using theme analysis and coding. According to the research findings, Iran's biopharmaceutical innovation ecosystem in the process of crossing its death valley has faced three types of challenges: implementation, integration and acceptance, which is the formation of five capabilities of interaction and accessibility; Integration and integration; Innovation and learning; Adaptability and mobility, and ultimately the ability to create complementarity, as well as the existence of three factors underlying government policies, political sanctions, and market demand, have been influential in crossing this valley and overcoming these challenges.